Resistencias genotípicas a los fármacos antirretrovirales en fracasos terapéuticos con pautas de alta eficacia

Gutiérrez, Félix; Moltó, José; Escolano, Clara; Mora, A; Pasquau, Francisco; Gregori, Joan; Nogueira, Enrique.
Med. clín (Ed. impr.) ; 115(11): 401-404, oct. 2000.
Artículo en Es | IBECS (España) | ID: ibc-6582

Documentos relacionados

  1. [Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy].
  2. Virologic Response Following a Switch to Dolutegravir-based Regimen in People Living with HIV/AIDS at a Tertiary Care Center in Nepal.
  3. In utero/peripartum antiretroviral therapy exposure and mental health outcomes at 8-18 years old: A longitudinal comparative study of children with perinatally acquired HIV, children perinatally HIV exposed but uninfected, and children unexposed uninfected from Uganda.
  4. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
  5. Phosphazide (nikavir) is a highly effective drug for the treatment of HIV/AIDS infection.
  6. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
  7. Rapid simultaneous analysis of anti human immunodeficiency virus drugs in pharmaceutical formulation by smart spectrophotometry based on multivariate calibration and least squares support vector machine methods.
  8. The freedom to grow.
  9. Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
  10. Early infant diagnosis of HIV infection using DNA-PCR at a referral center: an 8 years retrospective analysis.